publications-2007-2010

Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron

Published on 19 March 2015

Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron
Authors	Naskalska A, Szolajska E, Chaperot L, Angel J, Plumas J, Chroboczek J
Journal	Vaccine 27 (52), 7385-7393, 2009
Year	2009
Institute	iBS

Go back to list

Top page

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.

The Knowledge Factory

In the same section :

Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron

Browse the site

Alternative and Atomic Energies Agency

Browse the portal

The Knowledge Factory

About Fundamental Research Division

Research fields

Scientific results

In the same section :

Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron

Browse the site

Alternative and Atomic Energies Agency

Browse the portal